Pfizer says they are working on Omicron specific vaccine if needed.
Pfizer and BioNTech says its preliminary lab tests suggest a third dose of its vaccine is providing strong protection agains the Omicron variant.
With health officials urging people to get a third dose, Pfizer has released a study on whether booster shots of its COVID-19 vaccine may make an important difference.
The company says a booster dose may offer significant protection against the new Omicron variant even though the initial two doses appear significantly less effective.
Pfizer-BioNTech says its already working on creating an Omicron-specific vaccine and could have it ready for March of 2022 if needed.
Niagara Child Care Centres Moving
St. Catharines Holds Off Boulevard Planting
Man Charged with Gun and Drug Offences
Niagara Man Charged with Child Luring
St. Catharines Trying for Development Near Hospital
NRP Release Robbery Suspects Pics
Update: Police Charge Another Man, Other Charges Dropped
Speed Cameras Considered Near Schools